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Abstract
Wooden chest syndrome (WCS) describes a finding of fentanyl-induced skeletal muscle rigidity causing ventilatory failure.
Known primarily to anesthesiology, pulmonary, and critical care fields, WCS is a rare complication that may affect patients
of all ages if exposed to intravenous fentanyl, characterized by a patient’s inability to properly ventilate. Given the rise of
synthetic opioid deaths across the United States in the past decade, an understanding of all of fentanyl’s effects on the body
is necessary. In this article, we present a case of WCS in a patient with acute respiratory distress syndrome in a 61-year-old
female.
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Introduction
Fentanyl-induced chest wall rigidity, otherwise known as
wooden chest syndrome (WCS), is a rare complication of
intravenous fentanyl. Fentanyl is an opiate medication that is
often used in critical care and procedural settings as an analgesic paired with sedatives for intubated patients. We
describe a case of a patient intubated for acute respiratory
distress syndrome who developed a complication of WCS in
a medical intensive care unit.

Case Report
A 61-year-old female with a history of prior episodes of pancreatitis presented with a chief complaint of left-sided, sharp,
abdominal pain associated with nausea. Physical examination
demonstrated epigastric tenderness without rebound or guarding. Chest examination demonstrated strong inspiratory effort
and was negative for rales, rhonchi, or accessory muscle use.
Vital signs demonstrated no abnormalities and she had oxygen
saturations >92% on room air. Laboratory findings revealed
an elevated lipase of 1086 U/L (reference range: 10-140 U/L).
A diagnosis of pancreatitis was made. The patient was given
intravenous lactated Ringer’s solution. The patient developed
respiratory distress, and chest X-ray findings revealed pulmonary edema consistent with acute respiratory distress syndrome, requiring endotracheal intubation. She was sedated
initially with an intravenous fentanyl infusion at 50 µg/h. An

intravenous midazolam infusion at 1 mg/h was added to
achieve a Richmond Agitation-Sedation Scale goal of −4. The
fentanyl infusion was incrementally increased, roughly 50 to
75 µg/h per day, and ultimately maximized to 300 µg/h on
mechanical ventilation day 5. The dose of intravenous midazolam infusion reached 6 mg/h. On maximization of the
intravenous fentanyl infusion at 300 µg/h, the patient began
experiencing periods of hypoxia. The patient had received
roughly 11 000 µg (11.1 mg) of intravenous fentanyl when
these periods of hypoxia began. Physical examination at this
time was significant for a tense abdomen, facial cyanosis, and
episodes of what appeared to be breath-holding spells.
Ventilator readings revealed drastically elevated airway pressures. The patient required bag valve mask ventilation, which
was met by strong resistance. Passage of the suction catheter
revealed no obstruction or mucus. An emergent bedside bronchoscopy confirmed these findings. A repeat chest X-ray
revealed no pneumothorax. This presentation raised concern
for WCS. The intravenous fentanyl infusion was titrated down
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rapidly over a 3-hour period and she was transitioned to an
intravenous dexmedetomidine infusion at 0.2 mg/h in addition
to the intravenous midazolam infusion. The patient exhibited
no further episodes was successfully extubated 3 days later.

Discussion
Opioid-induced chest wall rigidity was first coined by
Hamilton and Cullen in 1953 when studying opioid effects
on respiratory depression.1 Since then, reports of patients
exhibiting similar reactions to opioids have been noted but
are quite limited. The term “wooden chest syndrome” has
since been adopted to describe these findings.1 Review of
literature suggests that a cohort of neonatal and pediatric
population is affected; however, no specific pattern of adult
patients has been observed.
The proposed mechanism of WCS is activation of µ-opioid
receptors in the central nervous system (CNS) via a dopaminergic pathway resulting in skeletal muscle rigidity.2
Lipophilicity is an important property in opioid delivery to the
CNS. Fentanyl is a highly lipophilic molecule, allowing for it
to readily cross the blood-brain barrier and interact with the
CNS. In addition, a study by Henthorn et al posits that an
active transporter may contribute to increased fentanyl levels
within the CNS.3 These findings may suggest why skeletal
chest wall rigidity is observed more so with fentanyl as compared with equivalent doses of other commonly used opioids.
Dose dependency, however, is debated. Some case reports
have demonstrated clinical findings of WCS with low doses of
fentanyl and rapid administration, while others report very
high doses in the form of infusions, as in our patient.2,4
Common physical examination findings in WCS are episodic “breath-holding spells,” tense abdominal muscles, a
firmly locked jaw, and stiff extremities. Hypoxia and hypertension are also common during these episodes, but no other
patterns of changes in vital signs are reported. One case
reported a fever to 103 °F; however, a concurrent diagnosis
of serotonin syndrome was made as well.5
These breath-holding spells are a manifestation of prolonged chest wall skeletal muscle contraction. The subsequent decreased chest wall compliance results in ineffective
assisted and spontaneous ventilation, translating to elevated
pressures within the ventilator circuit. Bag valve mask ventilation is exercised to combat hypoxia but is often met by a
high resistance.
When managing a ventilated patient for respiratory failure and increased peak pressures, early consideration of
WCS is helpful, yet ruling out other life-threatening causes
of hypoxia and elevated ventilator peak pressures is paramount. Spontaneous pneumothorax, mucus plugging, and/
or defects in the endotracheal tube and ventilator circuit
should be ruled out in a timely manner. A chest X-ray,
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passage of suction catheter, and, in some cases, an emergent
bedside bronchoscopy should be performed. When WCS is
suspected, there are 3 reported options for management. The
first option is administration of intravenous naloxone, an
opioid antagonist and reversal agent for opioid overdose.
This is the most common treatment and can result in rapid
reversal of chest wall rigidity.6 In patients requiring high
doses of fentanyl, the decision to administer naloxone
should be carefully considered as withdrawal symptoms
may rapidly follow. The second route of management is the
administration of neuromuscular blocking agents such as
rocuronium and cisatracurium. These agents competitively
block transmission of neuronal signaling at the level of nicotinic receptors, resulting in decreased skeletal muscle tone.
They are useful with ventilated patients early on in their
medical intensive care unit course and allow for the continued use of fentanyl. The last management route is cessation
of the offending agent. This decision can be made if the
patient is able to tolerate the time required for clearance of
fentanyl. In our case, fentanyl was rapidly titrated down and
resulted in cessation of ventilator desynchrony. In order to
maintain adequate sedation, other agents should be administered; in our case, dexmedetomidine and hydromorphone
were chosen.

Conclusion
Prolonged chest wall skeletal muscle contraction is a result
of fentanyl-bound µ-opioid receptors on the CNS and activation of a dopaminergic pathway. The subsequent decreased
chest wall compliance results in ineffective assisted and
spontaneous ventilation, translating to elevated pressures
within the ventilator circuit. Management of this syndrome is
with the opioid receptor antagonist Naloxone, neuromuscular blocking agents such as rocuronium, or cessation of fentanyl infusion with supportive care. In light of the coronavirus
disease 2019 pandemic and surge in intensive care unit
admissions, analgesic fentanyl use has risen. Therefore, an
understanding of this complication is necessary.
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